Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01888939 · ClinicalTrials.gov registry record · Phase 1

Effects of Interrupting Sedentary Behavior on Metabolic and Cognitive Outcomes in Children

A Phase 1 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Completed
Registry status
Phase 1
Development phase
89
Enrollment target

NCT01888939: Completed Phase 1 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NCT01888939 is a Phase 1 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 89 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (48% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01888939, a Phase 1 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

COMPLETED
Registry status
Phase 1
Development phase
89 participants
Enrollment target

Study Summary

Background: \- Some studies in adults have found that insulin and glucose blood levels are lower when a long period of sitting is broken up with walking, compared to sitting without breaks. This means that the body can better process sugars when there are walking breaks during the day. Researchers want to know if this is also true for children. Some studies have found that children s attention and memory might be better after exercise. Researchers want to know if short walking breaks have the same effects. Objectives: \- To understand if breaking up sitting with walking helps children s bodies better use sugars and improves children s concentration. Eligibility: \- Healthy children ages 7 to 11. Design: * Participants will be screened with a physical exam, medical history, exercise test, picture vocabulary test, and medical tests including blood tests and X-rays. * Participants will return for two 7-hour visits. In the month before the visits, they will wear a physical activity monitor for one week so researchers know how active they are. Once they will take the sitting only test and once the sitting breaks test. * During the sitting only test, participants will sit for 3 hours. * During the sitting breaks test, they will sit for 3 hours with 3-minute walking breaks every 30 minutes. * Both days, they will drink sugar water. Then the participants will have blood drawn from a needle that is kept in place, and they will wear a heart monitor. They will take attention and working memory tests on a computer and answer questions about how they feel. They will eat a meal at the end of the test day.

Interventions

  • OTHER Walking on a Treadmill
  • OTHER Sedendary Activities Only

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2013-06-26
Est. Completion 2018-01-29
Phase Phase 1

What the finished NCT01888939 record still lists

NCT01888939 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (48% higher).

The record links to 0 conditions, and to 2 interventions - of which Walking on a Treadmill is the first listed.

NCT01888939 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01888939 about?

NCT01888939 is a clinical study titled "Effects of Interrupting Sedentary Behavior on Metabolic and Cognitive Outcomes in Children". Background: \- Some studies in adults have found that insulin and glucose blood levels are lower when a long period of sitting is broken up with walking, compared to sitting without breaks. This means that the body can better process sugars when there are walking breaks during the day. Researchers ...

What is the current status of trial NCT01888939?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 89 participants. The study started on 2013-06-26. Estimated completion is 2018-01-29.

What interventions are being tested in trial NCT01888939?

The interventions under investigation include: Walking on a Treadmill (OTHER), Sedendary Activities Only (OTHER).

Who is sponsoring clinical trial NCT01888939?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01888939's enrollment target sits among peer trials

89 649th of 2000 higher than 1,351 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03682289 · 89 participants · Phase 2

    Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

  • NCT04787939 · 89 participants · NA

    Early Feeding After Oral Cavity Reconstruction

  • NCT05480449 · 89 participants · Phase 1

    Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

  • NCT05604131 · 89 participants · Phase 2

    Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01888939, the US trial registry maintained by the National Library of Medicine. NCT01888939 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.